genvec inc (GNVC:NASDAQ CM)
Wayne T. Hockmeyer Ph.D.
Chairman of The Board, Chairman of Compensation Committee and Member of Nominating and Corporate Governance Committee, GenVec, Inc.
|Age||Total Calculated Compensation||This person is connected to 67 board members in 6 different organizations across 14 different industries.|
See Board Relationships
Dr. Wayne T. Hockmeyer, Ph.D., served as the President of MedImmune Ventures Inc., a wholly-owned subsidiary of MedImmune Inc. from 2002 to June 1, 2007. Dr. Hockmeyer founded MedImmune, Inc. in April 1988 and served as its President and Chief Executive Officer from April 1988 to October 2000. From 1986 to 1988, he served as a Vice President of Research and Development at Praxis Biologics Inc. He was also employed at QIAGEN Gaithersburg, Inc. He has been Chairman of ...
910 Clopper RoadPhone: 240-632-0740
Gaithersburg, Maryland 20878
Board Members Memberships*
Chairman of The Board, Chairman of Compensation Committee and Member of Nominating and Corporate Governance Committee
Former Lead Independent Director, Chairman of Compensation Committee and Member of Executive Committee
Chairman, Member of Audit Committee, Member of Nominating Committee and Member of Corporate Governance Committee
Director, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee
Former Director, Member of Audit Committee and Member of Compensation Committee
Director, Chairman of Science & Technology Committee and Member of Finance Committee
University of Florida
Annual Compensation*There is no Annual Compensation data available.
|Jeffrey D. Abbey MBA, J.D.||Chief Executive Officer, President and Director|
Argos Therapeutics, Inc.
|Vijay B. Samant||Chief Executive Officer, President, Acting Chief Financial Officer and Director|
|Mark R. Baker J.D.||Chief Executive Officer, Director and Member of Science & Strategy Committee|
Progenics Pharmaceuticals, Inc.
|Daniel J. O’Connor Esq.||Chief Executive Officer, President and Director|
|Jonathan J. Lewis M.D., Ph.D.||Chief Executive Officer and Director|
ZIOPHARM Oncology, Inc.
|$600.0K||Compensation as of Fiscal Year 2013.|